Your browser doesn't support javascript.
loading
Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment.
Demosthenous, Christos; Lalayanni, Chrysavgi; Iskas, Michalis; Douka, Vassiliki; Pastelli, Nikoleta; Anagnostopoulos, Achilles.
Afiliação
  • Demosthenous C; Department of Hematology and HCT Unit, General Hospital of Thessaloniki "George Papanicolaou", Thessaloniki, Greece. Electronic address: christosde@msn.com.
  • Lalayanni C; Department of Hematology and HCT Unit, General Hospital of Thessaloniki "George Papanicolaou", Thessaloniki, Greece.
  • Iskas M; Department of Hematology and HCT Unit, General Hospital of Thessaloniki "George Papanicolaou", Thessaloniki, Greece.
  • Douka V; Department of Hematology and HCT Unit, General Hospital of Thessaloniki "George Papanicolaou", Thessaloniki, Greece.
  • Pastelli N; Department of Pathology, General Hospital of Thessaloniki "George Papanicolaou", Thessaloniki, Greece.
  • Anagnostopoulos A; Department of Hematology and HCT Unit, General Hospital of Thessaloniki "George Papanicolaou", Thessaloniki, Greece.
Curr Probl Cancer ; 43(3): 222-227, 2019 06.
Article em En | MEDLINE | ID: mdl-29895435
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Anticorpos Biespecíficos / Resistencia a Medicamentos Antineoplásicos / Antígenos CD19 / Leucemia-Linfoma Linfoblástico de Células Precursoras / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Anticorpos Biespecíficos / Resistencia a Medicamentos Antineoplásicos / Antígenos CD19 / Leucemia-Linfoma Linfoblástico de Células Precursoras / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2019 Tipo de documento: Article